Heterochiral Dipeptides of Chimeric Cyclic Amino Acids
Heterochiral Dipeptides of Chimeric Cyclic Amino Acids
批准号:
7350224
负责人:
Garland Ross Marshall
金额:
$30.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-01 至 2010-01-31
关键词:
AcidsAffinityAlanineAmino AcidsAminoisobutyric AcidsAntiviral AgentsBindingBinding SitesCXCR4 ReceptorsCyclic Amino AcidsCyclic PeptidesData AnalysesDevelopmentDipeptidesIsonipecotic AcidsLigandsMarshalMethodsMolecular ProbesNumbersObject AttachmentPeptide ReceptorPeptidesPotential EnergyPrincipal InvestigatorProlinePropertyRelative (related person)ResearchScreening procedureSideSurfaceTechniquesanalogbasechemokine receptorconformerdesignmolecular modelingmolecular recognitionnoveloncologyprogramsscaffoldtherapeutic targetthree dimensional structurevirtual
中文摘要
描述(由申请人提供):本研究的目的是开发多种肽“构象模板”作为分子探针,即满足至少三个要求的相对刚性支架:
(i)具有有限的3D结构(有限的明确的3D构象);
(ii)易于合成获得,并且
(iii)能够独特地定向肽侧链(α-β和β-γ键),所述肽侧链被认为在肽-受体相互作用期间传递大部分信息。
该提议提供了基于脯氨酸、氮杂脯氨酸、哌啶酸、氮杂哌啶酸、哌啶甲酸和异哌啶甲酸的嵌合氨基酸类似物的四环构象肽模板作为新的“特权支架”(嵌合氨基酸联合收割机结合了两种氨基酸的性质,一个实例是结合了D-和L-丙氨酸的空间性质的氨基异丁酸)。选择用于研究的配体是足够小的势能面可以通过DFT计算确定,和能量最小值和它们的相对能量评估。这为评估数据分析中要考虑的构象异构体的数量和相对能量提供了基础。将设计和合成新的化合物以引入共价约束,所述共价约束能够以最大的保真度对齐识别基序的氨基酸侧链,并且将通过分子建模的虚拟筛选来寻找与趋化因子受体的结合位点缺乏负空间相互作用。电化学助剂的新用途将允许在环状模板组装后连接侧链。开发特异性抑制的治疗靶点是CXCR 4受体,其具有作为抗病毒药物和肿瘤学的潜在应用。
英文摘要
DESCRIPTION (provided by applicant): The objective of this research is the development of a variety of peptide "conformational templates" as molecular probes, i.e. relatively rigid scaffolds that satisfy at least three requirements:
(i) possess limited 3D structures (limited well-determined 3D conformers);
(ii) be readily accessible synthetically, and
(iii) able to uniquely orient the peptide side chains (both alpha-beta and beta-gamma bonds) that are believed to transfer most of the information during peptide-receptor interactions.
This proposal offers tetracyclic conformational peptide templates based on chimeric amino acid analogs of proline, azaproline, pipecolic, azapipecolic, nipecotic and isonipecotic acids as novel "privileged scaffolds" (chimeric amino acids combine the properties of two amino acids, an example is aminoisobutyric acid that combines the steric properties of D- and L-alanine). The ligands chosen for study are sufficiently small that the potential energy surface can be determined by DFT calculations, and the energy minima and their relative energetics evaluated. This provide the basis for evaluating the number and relative energetics of conformers to be considered in data analysis. Novel compounds will be designed and synthesized to introduce covalent constraints that are able to align the amino-acid side chains of the recognition motif with greatest fidelity and lack of negative steric interaction with the binding site of chemokine receptors will be sought by virtual screening through molecular modeling. Novel uses of electrochemical auxiliaries will allow pendant side chains to be attached after the cyclic templates are assembled. The therapeutic target for development of specific inhibition is the CXCR4 receptor with potential applications as an antiviral and in oncology.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
c[D-pro-Pro-D-pro-N-methyl-Ala] adopts a rigid conformation that serves as a scaffold to mimic reverse-turns.
c[D-pro-Pro-D-pro-N-methyl-Ala] 采用刚性构象作为模拟回旋的支架。
DOI:
10.1002/bip.20869
发表时间:
2008
期刊:
Biopolymers
影响因子:
2.9
作者:
[Arbor,Sage, Kao,Jeff, Wu,Yun, Marshall,GarlandR]
通讯作者:
Marshall,GarlandR
3D modeling of the activated states of constitutively active mutants of rhodopsin.
视紫红质组成型活性突变体激活状态的 3D 建模。
DOI:
10.1016/j.bbrc.2006.04.058
发表时间:
2006
期刊:
Biochemical and biophysical research communications.
影响因子:
--
作者:
[Nikiforovich,GregoryV, Marshall,GarlandR]
通讯作者:
Marshall,GarlandR
Chemogenomics with protein secondary-structure mimetics.
具有蛋白质二级结构模拟物的化学基因组学。
DOI:
10.1007/978-1-60761-274-2_5
发表时间:
2009
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Marshall,GarlandR, Kuster,DanielJ, Che,Ye]
通讯作者:
Che,Ye
Conformational templates for rational drug design: flexibility of cyclo(D-Pro1-Ala2-Ala3-Ala4-Ala5) in DMSO solution.
合理药物设计的构象模板:环(D-Pro1-Ala2-Ala3-Ala4-Ala5)在DMSO溶液中的灵活性。
DOI:
10.1021/jm070084n
发表时间:
2007
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[Zhang,Xiaoming, Nikiforovich,GregoryV, Marshall,GarlandR]
通讯作者:
Marshall,GarlandR
Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
含有两个次膦酸基团的新型伪寡肽的设计、合成和金属结合。
DOI:
10.1002/bip.20855
发表时间:
2008
期刊:
Biopolymers
影响因子:
2.9
作者:
[Ye,Yunpeng, Liu,Min, Kao,JeffL-F, Marshall,GarlandR]
通讯作者:
Marshall,GarlandR
共 9 条
DISCOVERY OF NEW THERAPEUTICS FOR DRUG-FREE REMISSION OF HIV
-
批准号:8652488
-
项目类别:
-
资助金额:$39.86万
-
财政年份:2013
-
负责人:Garland Ross Marshall
-
依托单位:
DISCOVERY OF NEW THERAPEUTICS FOR DRUG-FREE REMISSION OF HIV
-
批准号:8915329
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2013
-
负责人:Garland Ross Marshall
-
依托单位:
DISCOVERY OF NEW THERAPEUTICS FOR DRUG-FREE REMISSION OF HIV
-
批准号:8838828
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2013
-
负责人:Garland Ross Marshall
-
依托单位:
DISCOVERY OF NEW THERAPEUTICS FOR DRUG-FREE REMISSION OF HIV
-
批准号:9058087
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2013
-
负责人:Garland Ross Marshall
-
依托单位:
DISCOVERY OF NEW THERAPEUTICS FOR DRUG-FREE REMISSION OF HIV
-
批准号:8540688
-
项目类别:
-
资助金额:$40.28万
-
财政年份:2013
-
负责人:Garland Ross Marshall
-
依托单位:
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
-
批准号:8364271
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2011
-
负责人:Garland Ross Marshall
-
依托单位:
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
-
批准号:8171849
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2010
-
负责人:Garland Ross Marshall
-
依托单位:
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
-
批准号:7956154
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2009
-
负责人:Garland Ross Marshall
-
依托单位:
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
-
批准号:7723284
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2008
-
负责人:Garland Ross Marshall
-
依托单位:
HYBRID PROTEIN ENGINEERING
-
批准号:7723254
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2008
-
负责人:Garland Ross Marshall
-
依托单位:
TARGETING PROTEIN INTERACTIONS AND DESIGNING CHIMERIC PROTEINS
-
批准号:7601547
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2007
-
负责人:Garland Ross Marshall
-
依托单位:
HYBRID PROTEIN ENGINEERING
-
批准号:7601517
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2007
-
负责人:Garland Ross Marshall
-
依托单位:
Heterochiral Dipeptides of Chimeric Cyclic Amino Acids
-
批准号:7010382
-
项目类别:
-
资助金额:$39.19万
-
财政年份:2005
-
负责人:Garland Ross Marshall
-
依托单位:
Heterochiral Dipeptides of Chimeric Cyclic Amino Acids
-
批准号:6865251
-
项目类别:
-
资助金额:$32.13万
-
财政年份:2005
-
负责人:Garland Ross Marshall
-
依托单位:
Heterochiral Dipeptides of Chimeric Cyclic Amino Acids
-
批准号:7179298
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2005
-
负责人:Garland Ross Marshall
-
依托单位:
Heterochiral Dipeptides of Chimeric Cyclic Amino Acids
-
批准号:7065752
-
项目类别:
-
资助金额:$5.97万
-
财政年份:2005
-
负责人:Garland Ross Marshall
-
依托单位:
COMPUTER AIDED DRUG DESIGN (CORE)
-
批准号:6665866
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2002
-
负责人:Garland Ross Marshall
-
依托单位:
COMPUTER AIDED DRUG DESIGN (CORE)
-
批准号:6486746
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2001
-
负责人:Garland Ross Marshall
-
依托单位:
COMPUTER AIDED DRUG DESIGN (CORE)
-
批准号:6336816
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2000
-
负责人:Garland Ross Marshall
-
依托单位:
CHARACTERIZATION OF THE RHODOPSIN/TRANSDUCIN INTERFACE
-
批准号:6164714
-
项目类别:
-
资助金额:$20.67万
-
财政年份:1998
-
负责人:Garland Ross Marshall
-
依托单位:
海外基金